Announcements Trials
Browse Landscape

Phase

Phase 2 13Phase NA 3Phase EARLY_PHASE1 3Phase 3 3Phase 1 3Phase 4 2Phase 1/2 2

Status

Completed 2Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 1

Conditions

Tuberous Sclerosis 1Multiple Myeloma 1Lymphangioleiomyomatosis 1

Interventions

Cyclophosphamide 142Gemcitabine 129Paclitaxel 125Radiotherapy 119Carboplatin 112Cisplatin 111pembrolizumab 110Nivolumab 106Docetaxel 90Rituximab 86Lenalidomide 77Dexamethasone 76Cytarabine 69Bevacizumab 64Fluorouracil 63Etoposide 63Oxaliplatin 62Filgrastim 59Peripheral Blood Stem Cell Transplantation 58Everolimus 58Capecitabine 58fludarabine phosphate 57Doxorubicin 56Temozolomide 55Prednisone 54Irinotecan 53Cetuximab 50fludarabine 48Ipilimumab 48Erlotinib Hydrochloride 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Completed × Simvastatin × Clear all
NCT02061397 2020-08-25

SOS

University of Pennsylvania

Phase 1/2 Completed
10 enrolled 6 charts

Tuberous Sclerosis, Lymphangioleiomyomatosis

NCT00281476 2011-11-01

The Effect of High Dose Simvastatine on Multiple Myeloma

Vejle Hospital

Phase 1/2 Completed
10 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡